<DOC>
	<DOCNO>NCT02376595</DOCNO>
	<brief_summary>The purpose study characterize dose-effect relationship rocuronium bromide adductor pollicis masseter muscle use pharmacokinetic-pharmacodynamic ( PKPD ) model . The hypothesis masseter muscle great sensitivity neuromuscular blocker ( rocuronium ) , faster onset slow recovery profile adductor pollicis muscle .</brief_summary>
	<brief_title>Pharmacokinetic Pharmacodynamic Rocuronium</brief_title>
	<detailed_description />
	<mesh_term>Rocuronium</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<criteria>Scheduled elective surgery general anesthesia . Pregnancy . Body mass index ( BMI ) &gt; 25 kg/m2 . Anticipated difficult airway . Surgery associate great volume loss . Presence neuromuscular , hepatic , renal , cardiac respiratory disease . Previous history neuromuscular blockade allergy , and/or administration drug know interfere neuromuscular blockade</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Rocuronium</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamics</keyword>
</DOC>